Arbutus Biopharma ABUS
NASDAQ ABUS
$3.71 -0.11 (-2.87%)
As of: Nov 11, 2026 · 9:35 AM EST

Arbutus Biopharma (ABUS) Price to FCF (2012 - 2026)

Updated

Arbutus Biopharma's (ABUS) Price to FCF came in at 130.81 for Q1 2014.

Analysis

Arbutus Biopharma (ABUS) Price to FCF (2012 - 2026) Analysis & Trends

For FY2012, Arbutus Biopharma's Price to FCF stood at 2.14.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Arbutus Biopharma 758.95 Mn 142.14 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 4.30
Mar 31, 2014 122.66
Sep 30, 2013 5.76
Jun 30, 2012 4.32
API Access

Arbutus Biopharma Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=ABUS&period=max&api_key=YOUR_API_KEY